http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

uloric is a xanthine oxidase xo inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol who are intolerant to allopurinol or for whom treatment with allopurinol is not advisable for the safe and effective use of allopurinol see allopurinol prescribing information uloric is a xanthine oxidase xo inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol who are intolerant to allopurinol or for whom treatment with allopurinol is not advisable 1 for the safe and effective use of allopurinol see allopurinol prescribing information limitations of use uloric is not recommended for the treatment of asymptomatic hyperuricemia 1 limitations of use uloric is not recommended for the treatment of asymptomatic hyperuricemia

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_1920 DOID_1920

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB04854 drugbank:DB04854

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-06-12T11:28:40.734Z

http://purl.org/np/RAF-4-wPzM... RAF-4-wPzM

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-06-12T11:28:40.734Z